Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - asparagine 3,4 mg/ml; glutamic acid 5,6 mg/ml; valine 7,3 mg/ml; arginine 11,3 mg/ml; leucine 7,9 mg/ml; serine 4,5 mg/ml; proline 6,8 mg/ml; alanine 16 mg/ml; lysine acetate 12,7 mg/ml - eq. lysine 9 mg/ml; histidine 6,8 mg/ml; threonine 5,6 mg/ml; tryptophan 1,9 mg/ml; glycyl-l-glutamine 30,27 mg/ml; glycyl-l-tyrosine 3,45 mg/ml; isoleucine 5,6 mg/ml; methionine 5,6 mg/ml; phenylalanine 5,85 mg/ml - solution for infusion - glycyl-l-glutamine 30.27 mg/ml; histidine 6.8 mg/ml; glutamic acid 5.6 mg/ml; glycyl-l-tyrosine 3.45 mg/ml; leucine 7.9 mg/ml; isoleucine 5.6 mg/ml; methionine 5.6 mg/ml; lysine acetate 12.7 mg/ml; phenylalanine 5.85 mg/ml; proline 6.8 mg/ml; serine 4.5 mg/ml; threonine 5.6 mg/ml; tryptophan 1.9 mg/ml; alanine 16 mg/ml; asparagine 3.4 mg/ml; arginine 11.3 mg/ml; valine 7.3 mg/ml - amino acids

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius kabi malaysia sdn. bhd - alanine; aspartic acid; isoleucine; glutamic acid; arginine; leucine; histidine; methionine; phenylalanine; proline; serine; threonine; tryptophan; valine; lysine acetate; glycyl-l-glutamine h20; glycyl-l-tyrosine 2h20 -

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - alanine 16 g/l;  ;  ;  ; arginine 11.3 g/l;  ;  ; aspartic acid 3.4 g/l;  ;  ; glutamic acid 5.6 g/l;  ;  ; glycyl-l-glutamine 30.27 g/l;  ; glycyl-l-tyrosine 3.45 g/l; histidine 6.8 g/l;  ;  ; isoleucine 5.6 g/l;  ;  ;  ; leucine 7.9 g/l;  ;  ;  ; lysine acetate 12.7 g/l;  ;  ;  ; methionine 5.6 g/l;  ; phenylalanine 5.85 g/l;  ;  ;  ;  ; proline 6.8 g/l;  ; serine 4.5 g/l;  ;  ;  ; threonine 5.6 g/l;  ;  ;  ; tryptophan 1.9 g/l;  ;  ; valine 7.3 g/l;  ;   - solution for infusion - 134 g/l - active: alanine 16 g/l       arginine 11.3 g/l     aspartic acid 3.4 g/l     glutamic acid 5.6 g/l     glycyl-l-glutamine 30.27 g/l   glycyl-l-tyrosine 3.45 g/l histidine 6.8 g/l     isoleucine 5.6 g/l       leucine 7.9 g/l       lysine acetate 12.7 g/l       methionine 5.6 g/l   phenylalanine 5.85 g/l         proline 6.8 g/l   serine 4.5 g/l       threonine 5.6 g/l       tryptophan 1.9 g/l     valine 7.3 g/l     excipient: citric acid monohydrate water for injection - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate to severe catabolic status.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - alanine arginine aspartic acid glutamic acid glycyl - glutamine monohydrate glycyl -tyrosine dihydrate histidine isoleucine leucine lysine acetate methionine phenylalanine proline serine threonine tryptophan, l- valine - solution for infusion - %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - alanine arginine aspartic acid glutamic acid glycyl - glutamine monohydrate glycyl -tyrosine dihydrate histidine isoleucine leucine lysine acetate methionine phenylalanine proline serine threonine tryptophan, l- valine - solution for infusion - 250 millilitre

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - phenylalanine; tryptophan; alanine; glycylglutamine monohydrate; valine; aspartic acid; serine; glutamic acid; glycyltyrosine dihydrate; histidine; leucine; isoleucine; methionine; lysine acetate; proline; threonine; arginine -

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - alanine, quantity: 16 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g); histidine, quantity: 6.8 g/l; methionine, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; threonine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: glycine, qty 10.27 g; equivalent: lysine, qty 9 g); valine, quantity: 7.3 g/l; arginine, quantity: 11.3 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; leucine, quantity: 7.9 g/l; isoleucine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l - injection, intravenous infusion - excipient ingredients: water for injections; citric acid - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - proline, quantity: 6.8 g/l; isoleucine, quantity: 5.6 g/l; methionine, quantity: 5.6 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); serine, quantity: 4.5 g/l; glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glycine, qty 10.27 g; equivalent: glutamine, qty 20 g); alanine, quantity: 16 g/l; histidine, quantity: 6.8 g/l; glutamic acid, quantity: 5.6 g/l; tryptophan, quantity: 1.9 g/l; leucine, quantity: 7.9 g/l; valine, quantity: 7.3 g/l; aspartic acid, quantity: 3.4 g/l; phenylalanine, quantity: 5.85 g/l; glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - glycine 5,31 mg/ml; valine 8,7 mg/ml; arginine 8,2 mg/ml; leucine 12,8 mg/ml; serine 7,6 mg/ml; proline 3 mg/ml; alanine 6,2 mg/ml; lysine acetate 16,9 mg/ml - eq. lysine 12 mg/ml; histidine 9,8 mg/ml; threonine 8,2 mg/ml; tryptophan 3 mg/ml; glycyl-l-tyrosine 3,16 mg/ml; tyrosine 0,6 mg/ml; isoleucine 5,8 mg/ml; methionine 2 mg/ml; phenylalanine 3,5 mg/ml; acetylcysteine 0,54 mg/ml - solution for infusion - glycine 5.31 mg/ml; isoleucine 5.8 mg/ml; glycyl-l-tyrosine 3.16 mg/ml; histidine 9.8 mg/ml; methionine 2 mg/ml; lysine acetate 16.9 mg/ml; leucine 12.8 mg/ml; phenylalanine 3.5 mg/ml; serine 7.6 mg/ml; proline 3 mg/ml; threonine 8.2 mg/ml; tryptophan 3 mg/ml; tyrosine 0.6 mg/ml; acetylcysteine 0.54 mg/ml; alanine 6.2 mg/ml; arginine 8.2 mg/ml; valine 8.7 mg/ml - amino acids

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - glycyltyrosine dihydrate, quantity: 3.45 g/l (equivalent: tyrosine, qty 2.28 g; equivalent: glycine, qty 0.94 g); histidine, quantity: 6.8 g/l; alanine, quantity: 16 g/l; lysine acetate, quantity: 12.7 g/l (equivalent: lysine, qty 9 g; equivalent: glycine, qty 10.27 g); glycylglutamine monohydrate, quantity: 30.27 g/l (equivalent: glutamine, qty 20 g; equivalent: glycine, qty 10.27 g); glutamic acid, quantity: 5.6 g/l; phenylalanine, quantity: 5.85 g/l; valine, quantity: 7.3 g/l; leucine, quantity: 7.9 g/l; tryptophan, quantity: 1.9 g/l; methionine, quantity: 5.6 g/l; isoleucine, quantity: 5.6 g/l; serine, quantity: 4.5 g/l; proline, quantity: 6.8 g/l; arginine, quantity: 11.3 g/l; threonine, quantity: 5.6 g/l; aspartic acid, quantity: 3.4 g/l - injection, intravenous infusion - excipient ingredients: citric acid; water for injections - glamin provides amino acids as part of parenteral nutrition therapy, when oral or enteral nutrition is impossible, insufficient or contraindicated especially in patients with a moderate or severe catabolic status.